| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0197-2456(97)00026-3 |
| P698 | PubMed publication ID | 9315424 |
| P2093 | author name string | Peduzzi P | |
| Iwane M | |||
| Donta S | |||
| P2860 | cites work | Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88 | Q57111471 |
| A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children | Q57111592 | ||
| Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area | Q57938358 | ||
| Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups | Q67492593 | ||
| Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity | Q67503933 | ||
| Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers | Q67561530 | ||
| On sample sizes to estimate the protective efficacy of a vaccine | Q68043021 | ||
| Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use | Q68128363 | ||
| Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination | Q70704019 | ||
| Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study | Q72238717 | ||
| A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease | Q72695855 | ||
| A New Design for Randomized Clinical Trials | Q28239541 | ||
| Final report on the aspirin component of the ongoing Physicians' Health Study | Q29619461 | ||
| Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. | Q34326253 | ||
| Familial clustering of hepatitis B virus infections and prevention of perinatal transmission by immunization with a reduced number of doses in an area of intermediate endemicity (Tunisia). | Q38954845 | ||
| Efficacy trial of malaria vaccine SPf66 in Gambian infants | Q38959070 | ||
| Efficacy of measles vaccines after controlling for exposure | Q39017856 | ||
| A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela | Q39311175 | ||
| Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. | Q39389427 | ||
| Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants | Q40687188 | ||
| Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. | Q40694949 | ||
| Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group | Q40713120 | ||
| The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians | Q41501749 | ||
| Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization | Q42286797 | ||
| Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. | Q43208959 | ||
| Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren | Q43208988 | ||
| Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador | Q43598911 | ||
| The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity | Q43693803 | ||
| Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. | Q45081794 | ||
| Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults | Q45785388 | ||
| Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly | Q45868418 | ||
| Protective efficacy of high-titre measles vaccines administered from the age of five months: a community study in rural Senegal. | Q46157541 | ||
| Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study. | Q48004931 | ||
| Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia | Q48013751 | ||
| Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials | Q52570205 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| vaccine engineering | Q14861085 | ||
| P304 | page(s) | 397-419 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Contemporary Clinical Trials | Q5164971 |
| P1476 | title | A review of the design of vaccine efficacy trials and a proposal for the design of the VA Cooperative Study of Active Immunotherapy of HIV Infection | |
| P478 | volume | 18 |
Search more.